Healthcare Stocks on Major News: NASDAQ:VOLC, NASDAQ:CASM, NASDAQ:MGCD, NASDAQ:ATRC
Los Angelas, CA – (MeshPress) — 07/21/2014 - Volcano Corporation (NASDAQ:VOLC) is very active today and traded between $15.65 – 15.91 with total traded volume of 183,462.00 shares. At a current price of 15.90, VOLC is +0.08 – +0.51% from the previous close of $15.82. Moreover, At Current Market Price, VOLC is in distance of -9.50% from its 50-day Moving Average price of $17.5691 and -18.56% from its 200-day Moving Average price of $19.5225. Volcano Corporation designs, develops, manufactures and commercializes a range of precision guided therapy tools, including intravascular ultrasound (IVUS), and fractional flow reserve (FFR), products.
How To Trade VOLC Now After The Recent Volatile Moves? Find Out Here
Shares of CAS Medical Systems, Inc. (NASDAQ:CASM) are trading at $1.96 and is -1.89% of its 50-day Moving Average price of $1.9977 and -6.83% from its 200-day Moving Average price of $2.1037. The average trading volume is 14284 shares and its market capitalization is $37.6M. CAS Medical Systems, Inc. is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products that is vital to patient care. The Company’s products include the FORE-SIGHT Absolute Tissue Oximeter and sensors, and the Company’s Traditional Monitoring products which include MAXNIBP blood pressure measurement technology, bedside monitoring products, and neonatal vital signs supplies.
What Should Investors Do With CASM Now? Find Out Here
MGC Diagnostics Corporation (NASDAQ:MGCD) reported EPS of 0.375. For the Current Fiscal year, the company is expected to report EPS of 0.33. For the Next Quarter and Next Year, the company is expected to report EPS of 0.23 and 0.64 respectively. At Current Market Price, MGCD is in distance of -4.91% from its 50-day Moving Average price of $8.5606 and -21.56% from its 200-day Moving Average price of $10.3771. MGC Diagnostics Corporation is a global medical technology company dedicated to cardiorespiratory health solutions. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products through its Medical Graphics Corporation subsidiary under the MGC Diagnostics brand and trade name.
Why Should Investors Consider Buying MGCD Now? Find Out Here
AtriCure, Inc. (NASDAQ:ATRC) reported EPS of -0.793. For the Current Fiscal year, the company is expected to report EPS of -0.87. For the Next Quarter and Next Year, the company is expected to report EPS of -0.18 and -0.66 respectively. At Current Market Price, ATRC is in distance of -8.89% from its 50-day Moving Average price of $17.2874 and -14.29% from its 200-day Moving Average price of $18.3758. AtriCure, Inc. is a medical device company. The Company develops, manufactures and sells cardiac surgical ablation systems designed to create lesions, or scars, in cardiac, or heart, tissue and devices for the exclusion of the left atrial appendage. The Company has two primary product lines for the ablation of cardiac tissue.
Is ATRCS A Buy Or Sell At These Levels? Find Out Here
Text PRO to 555888 using your cell phone to join our list
- Hot Bio-Tech Active Gainers (OTCMKTS:DRIO, NASDAQ:OCRX, NASDAQ:ORGS, NASDAQ:PCYC)
- Healthcare Stocks on Major News: NASDAQ:VOLC, NASDAQ:CASM, NASDAQ:MGCD, NASDAQ:ATRC
- Healthcare Stocks Gain Amazing Volumes (OTCMKTS:ACHI, NASDAQ:MDAS, NASDAQ:CTRX, NASDAQ:HMSY)
- Options Check-Up: NYSE:PHG, NYSE:MR, NYSE:PKI, NYSE:WAT
- News Bulletin of the Big Biotech Companies: NYSE:PFE, NYSE:OCR, NYSE:THC, NYSE:UNH